The Search for Solutions to Diabetic Kidney Disease Diabetic kidney disease is a pressing concern, often leading to end-stage renal disease (ESRD) and significantly elevating the risk of cardiovascular events
A better understanding of the pathophysiology is necessary for better phenotyping of MAFLD patients and development of diagnostic noninvasive markers and novel therapeutic agents
The ICT Mentorship Core Content Month 1 Summarized:
The report was uncontrolled, unblinded, not randomized, had no comparator arm, used patient-reported outcomes rather than validated pain instruments, and did not publish dose, effect size, confidence intervals, p-values, or systematically collected adverse events limitations that severely constrain any clinical inference
INTERACTIONS An interaction between L-carnitine and coumarin drugs cannot be excluded